-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
February 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … predominantly symptom-
management options; however, emerging research aims to identify disease-modifying therapies … AD pathogenesis, leading researchers to investigate intranasally delivered insulin as a
potential therapy … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central … Intranasal
insulin therapy for Alzheimer disease and
amnestic mild cognitive impairment: a pilot
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … Helminthic therapy (pig whipworm) for treatment-resistant ulcerative colitis No high-impact potential … POEM was ineffective in
three patients because of severe submucosal fibrosis attributed to previous therapies … Finally, one
expert representing a clinical perspective stated that no therapies are available to promote
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - therapeutic effects and better glycemic control. … therapeutic effects and better glycemic control. … Both anti-angiogenic and corticosteroid treatments require ongoing treatment involving multiple
intravitreal … Topical collection on lipid and
metabolic effects of gastrointestinal surgery. … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
June 01, 2014 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … cognitive behavior therapies. … efficacy for suicidal ideation
and as an adjunct treatment to behavior and brain-stimulation therapies … added to existing therapies. … Therapeutic options in
treatment-resistant depression. Ann Med. 2011
Nov;43(7):512-30.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
May 26, 2017 - vary for different
children and may include combinations of behavioral therapies,
educational therapies … , medical and related therapies, approaches
targeting sensory issues, and allied health therapies; parents … explicitly
stated. the key questions were fair and similar to those one would
want to know about any therapy … medical treatment alone is used when
there is poor access to non-medical therapies. … and the sensory therapies the writing is
focused on these therapies; there is not a need for extensive
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
April 03, 2013 - therapies. … Second, not all of these treatments are cognitive-behavioral therapy. … because they can influence treatment adherence and
therapeutic response. "
This is a very key statement—good … as CBT-mixed; her treatment is one of the purest cognitive therapies around. … such as Present-Centered Therapy or treatment as usual as a control.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
December 20, 2018 - separating early from late disease, however one
defines these stages, is not to assess whether certain
therapeutics … Others have stated, “It has been postulated that
the early stages of RA may, therefore, offer a therapeutic … The use of the 1/RR was primarily for comparisons of
combined therapies to MTX monotherapy. … its earlier stage than later but I don't think there are data
suggesting that responses to specific therapeutic … like
massage, physical and occupational therapy, meditation, and
other complementary therapies can
-
effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery
innovations that address … *Platelet-rich plasma therapy for treatment of osteoarthritis Moderately high
6. … provided by PRP for knee OA was 9 months.
27
Autologous PRP is not currently considered a drug or a therapeutic … for Treatment of Osteoarthritis
Platelet-Rich Plasma Therapy for Treatment of Osteoarthritis
Rheumatoid
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
January 01, 2020 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … for pain management or help with treating opioid dependence, interventions include
detoxification treatments … , opioid replacement therapy (i.e., methadone or buprenorphine
maintenance therapy), or other inpatient
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … All experts generally indicated that these antiobesity therapies have high potential to meet a
significant … the company in March 2011.
57
As of July 25, 2011, the system had
been approved by the Australian Therapeutic … Goods Administration for inclusion in its therapeutic
goods registry for treatment of T2DM and obesity … Orexigen Therapeutics provides a regulatory
update on Contrave NDA. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … New drug treatment options are needed for obese patients seeking
medical therapy for weight loss. … with antiobesity pharmacotherapies and potential
third-party payers’ unwillingness to cover these therapies … Goods Administration for inclusion in its therapeutic
goods registry for treating T2DM and obesity
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-207-ptsd-disposition-comments.pdf
May 17, 2018 - SR in 2013 of
psychological therapies for chronic PTSD) have classified
CBT treatments (that are not … other specific therapies,
such as cognitive therapy, cognitive processing therapy,
etc.) as trauma-focused … • Cognitive processing therapy
• Cognitive restructuring
• Exposure-based therapies
• Coping skills … therapy
• Various “mixed” therapies
Eye movement desensitization and reprocessing
Other psychological … or behavioral therapies
• Psychodynamic therapy
• Interpersonal therapy
• Group therapy
• Hypnosis
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - Many patients with T2DM fail to meet treatment goals and require additional
therapy with one of two … One expert with a clinical perspective also noted that
initiation of treatment with this therapy might … Both treatments
were generally well tolerated. … compliance
Experts agreed that while any new therapy for the treatment of diabetes would be welcome … of T2DM
Intervention
SGLT2 inhibitors for treatment of T2DM
While many current treatments help
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … recently and will be used in place of existing treatments
in some patients and as an addition to treatment … Although cost information is not yet available, oral
microbiome-based therapeutics (i.e., capsules) … Hypertension Therapeutic device $1,000,000,000 $500,000,000
Lomitapide (Juxtapid) for Treatment … Competition could eventually lower the price of of these
treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-surveillance-report-1-updated_0.PDF
December 01, 2021 - Comparative Effectiveness Review No. 250: Living Systematic Review on Cannabis and Other Plant-Based Treatments … for Chronic Pain
1
Living Systematic Review on Cannabis
and Other Plant-Based Treatments for
Chronic … quarterly progress report for an ongoing living systematic review on
Cannabis and other Plant-based Treatments … other, or another
treatment. … Living Systematic
Review on Cannabis and Other Plant-Based Treatments for Chronic Pain – Quarterly Progress
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
August 27, 2012 - Suppose this example if you want to get the best
treatment we have to choose for best treatments we … During in-person meeting we had presentations by topical
experts or content experts in order for the … that a number of stakeholder
groups, again, we had 61 different stakeholder groups
identify 9 broad topical … Vasomotor symptoms
are related to hormone replacement therapy. … These caregivers often are people who are
making or helping to make therapeutic decisions.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0491-140827.pdf
February 19, 2014 - National Institute for Health and Care
Excellence (NICE), entitled Lung cancer: the diagnosis and treatment … Chest.
2013; 143(5 Suppl):e211S-50S.
§ Lung cancer: the diagnosis and treatment of lung cancer. … Improper use of imaging modalities
may lead to incorrect staging and treatment planning for patients
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Effective treatments are needed. … Patients with AS who did not respond to prior treatment with
TNF therapies showed significant improvement … Secukinumab (Cosentyx) for Treatment of Psoriatic Arthritis
Key Facts: Current treatments for PsA … Clinical Pathway at Point of This Intervention
AS treatment focuses on physical therapy and exercise
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
June 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Current treatments for OA include over-the-counter
pain medication, exercise and/or physical therapy … Autologous MSCs have also been given with other therapies,
including platelet-rich plasma (PRP) therapy … The therapy could provide a major advance in treatment for many patients if it
becomes the first therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0320_06-17-2009.pdf
January 01, 2009 - Outcome(s): Comparative diagnostic, prognostic, and therapeutic accuracy; cost
savings (e.g., decreased … Is there improved diagnostic and/or therapeutic accuracy for FLC analysis in
conjunction with serum … compared with the current practice of
performing urine and serum electrophoresis for diagnosis and therapy … implications of routinely measuring serum FLC in
conjunction with serum electrophoresis for diagnosis and/or therapy … What is the diagnostic and/or therapeutic monitoring utility of the К/λ ratio?
4.